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A B S T R A C T
The purpose of this study was to determine whether abnormal antepartum cervical
cytologic findings result in differing postpartum regression rates. Between 1993 and
2000, 107 pregnant women with antepartum abnormal cervical cytologic findings were
identified. Papanicolaou smear data were separated into three groups by use of the CIN
classification system. Postpartum regression rates of antepartum Papanicolaou smears
were analyzed six months after delivery. Normalization of Papanicolaou smears in the
postpartum period were observed in 50 of 107 women (46.7%). Regression of cervical cy-
tologic findings was noted in 61 of 107 women (57%). Respectively, persistence of Papa-
nicolaou smear was noted in 43 of 107 patients (40%). Only 3 of 107 (3%) antepartum
findings progressed after delivery. Desquamation of the cervical epithelium or enhance-
ment of a localized reparative immunologic response after vaginal delivery could play
an important role in the spontaneous regression of cervical dysplasia in the postpartum
period.
Introduction
Worldwide, cervical cancer continues
to be an important cause of morbidity and
mortality. While the refinement of cyto-
logic screening techniques and programs
for early detection have been associated
with a decreasing risk of invasive dis-
ease, diagnostic and management prob-
lems associated with precursor lesions
have become more important. After con-
sidering the relevant literature since
1950, Ostor concluded that the probabil-
ity of cervical intraepithelial lesions be-
coming invasive increases with the sever-
ity of the atypia, progression to invasion
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does not always occur, and even the hig-
her degrees of atypia may regress1. After
considering many series with varying de-
grees of follow-up, he quotes approximate
rates of regression as being 57% for cervi-
cal intraepithelial neoplasia (CIN) I, 43%
for CIN II, and 32% for CIN III. The rates
of progression to invasive cancer are thought
to be 1%, 5%, and 12%, respectively1.
The reported incidence of abnormal
cervical cytology during pregnancy varies
considerably, depending on risk factors of
the screened population2. Abitbol and co-
workers, in a retrospective review of
13,000 pregnant patients, reported an in-
cidence of abnormal cervical smears of
2.2%, and, Lurain and associates repor-
ted an incidence of 1.3%3,4. The risk of car-
cinoma in situ (CIS) in pregnancy is low-
er, with an incidence as low as 0.025%;
however, in a review, Hacker and col-
leagues reported a prevalence for CIS of
1.3 in 1,000 pregnancies, suggesting a
trend toward an increased incidence3–6.
Prospective evaluations of pregnant wo-
men using abrasive cytology indicates a
1.8% risk of abnormal smears, and an
8.5% risk in a university population7,8.
Additionally, the incidence of human pa-
pilloma virus associated cytologic abnor-
malities discovered during pregnancy
may be as high as 28%9–11.
Pregnancy represents an ideal time to
screen for cervical cancer because most
women receive prenatal care. The safety,
acceptance and routine use of antenatal
cervical cytologic screening is responsible
for increasing the number of abnormal
cervical smears.
Some authors describe pregnancy as
having no effect on CIN, whereas others
have reported higher regression rates of
cervical dysplasia in the postpartum pe-
riod compared with spontaneous regres-
sion rates of dysplasia for nonpregnant
women12–14.
The objective of this study is to deter-
mine whether abnormal antepartum cer-
vical cytologic findings result in differing
postpartum regression rates.
Subjects and Methods
Between 1993 and 2000, 107 subjects
were recruited from pregnant women un-
dergoing regular checkups, with abnor-
mal cervical cytologic findings after their
initial antepartum visit. The subjects
were identified through clinic and cyto-
logic data, and they were prospectively
followed cytologically and colposcopically
during pregnancy and six months after
delivery. All patients signed an informed
consent form before acceptance into the
study. Data were collected for age, gra-
vidity, parity, smoking history, history of
sexually transmitted diseases, cervical
cytologic findings, colposcopic evaluation,
postpartum biopsies and postpartum
treatment. All patients underwent a Pa-
panicolaou test using a spatula and cot-
ton-tipped swab.
The terminology for cytologic findings
were adjusted to the CIN (cervical in-
traepithelial neoplasia) classification sys-
tem15. The initial antepartum cytologic
data were separated into three groups:
mild dysplasia was classified as CIN I,
moderate dysplasia as CIN II, and severe
dysplasia and carcinoma in situ as CIN
III15–16. CIN I was classified as low-grade
disease, but CIN II and CIN III were clas-
sified as high-grade disease15–16. The in-
dications for colposcopy were CIN II and
CIN III (high grade disease). In the event
of abnormal cervical cytologic findings,
Papanicolaou tests were repeated every 3
months during the antepartum period,
and six months after delivery. A colpos-
copy was repeated in 2 or 3 months if the
transformation zone was not fully visual-
ized. All women delivered vaginally. Post-
partum evaluation consisted of a Papa-
nicolaou smear for all women six months
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after delivery. Colposcopy and biopsy we-
re performed in cases with Papanicolaou
test CIN II or CIN III. Finally, antepar-
tum and postpartum cervical cytologic
findings were compared.
Statistical analysis was performed us-
ing Statistics for Windows (Stat Soft Inc,
USA, Version 6.0). All data were analyzed
using a descriptive analysis. Chi-square
analyzing was used to compare CIN va-
lue in pregnancy and after delivery. Find-
ings with an error probability value of <
0.05 were considered to be statistically
significant.
Results
In the study interval, 107 pregnant
women underwent cervical cytologic ex-
amination. The age of the group of wo-
men undergoing examination ranged
from 22 to 37 years with a mean of 28.6
years ( 6.1 years), and parity median was
2. 23% were smokers, and 7% had a his-
tory of Chlamydia trachomatis.
Table 1. depicts antepartum and post-
partum cervical cytologic findings; notice-
ably are the regression and persistence
rates of CIN I, CIN II and CIN III in the
postpartum period. Normalization of Pa-
panicolaou smears in the postpartum pe-
riod were observed in 46 (62.2%) women
with antepartum finding CIN I, 2 (9.5%)
patients with antepartum finding CIN II,
and in 2 (16.7%) women with antepartum
finding CIN III (Table 1). It is interesting
that total of 50 (46.7%) antepartum ab-
normal Papanicolaou smears became
normal post partum. Total cytologic re-
gression was noted in 61 of 107 women
(57%). Persistence of the antepartum fin-
dings were observed in 26 (35.1%) pa-
tients with CIN I, 12 (57.1%) with CIN II,
and 5 (41.6%) women with CIN III in the
postpartum period. Cytological findings
in Papanicolaou smears after delivery
was not changed in 43 (40%) of 107 pa-
tients (CIN I in 26, CIN II in 12 and CIN
III in 5 women), compared to findings
during pregnancy (Table 1). Only 3 (3%)
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TABLE 1




Cytological findings after delivery
Total
Negative CIN I CIN II CIN III
CIN I 46 (62.2%) 26 (35.1%) 2 (2.7%) – 74 (69.2%)
CIN II 2 (9.5%) 6 (28.6%) 12 (57.1%) 1 (4.8%) 21 (19.6%)
CIN III 2 (16.7%) 2 (16.7%) 3 (25.0%) 5 (41.6%) 12 (11.2%)
Total 50 (46.7%) 34 (31.8%) 17 (15.9%) 6 (5.6%) 107 (100%)
TABLE 2







CIN I 74 (69.2) 34 (31.8) 0.0016
CIN II 21 (19.6) 17 (15.9) 0.5498
CIN III 12 (11.2) 6 (5.6) 0.1743
*  test
antepartum cytologic findings progressed
after delivery: two CIN I to CIN II, and
one CIN II to CIN III (Table 1). Com-
paring antepartum and postpartum cer-
vical cytologic findings, significant re-
gression of CIN I (p = 0.0016), but not
CIN II and CIN III (Table 2) was seen.
Cytologic progression to invasive cervical
cancer was not observed. Finally, 21
(19.6%) postpartum patients underwent
colposcopic examination and cervical bi-
opsy because of CIN II and CIN III Pa-
panicolaou test. Six cases of CIN III were
found on pathologic examination (Table
3). »Cold knife« conization were perfor-
med in these six patients.
Discussion
Recent studies have shown that eradi-
cation of cervical cancer is an unrealistic
goal, and that maximal safety from the
cancer after a negative smear is approxi-
mately 90%, which remains roughly the
same during several years after the
test17. An organized surveillance pro-
gram consists of several essential ele-
ments, including high follow-up rates,
quality control of cervical cytology, and
referral of confirmed cases for adequate
treatment. These elements allow for qua-
lity control, monitoring of the process and
evaluation of outcome. Epidemiologic stu-
dies of CIN during pregnancy have exhib-
ited varying outcomes11,13,14. Many col-
poscopists believe that a cytology test re-
sult of high-grade disease (CIN II, III) in
a pregnant patient requires special con-
sideration. Pregnancy accentuates both
normal and abnormal colposcopic find-
ings, and clinicians may not obtain ap-
propriate cervical biopsies out of concern
of increased bleeding12,18. Although cervi-
cal biopsy during pregnancy is associated
with an increased risk of minor bleeding,
it has not been associated with increased
rates of major bleeding or pregnancy loss
in large studies, and a failure to perform
cervical biopsies in pregnant women has
been associated with missed cancers19.
Because of the risk of potential injury to
the fetus, endocervical sampling is pro-
scribed during pregnancy. However, ma-
ny authors believe CIN is not accelerated
by pregnancy. In fact, cervical dysplasia
often regresses completely in the post-
partum period12,13. In a study by Hall and
Walton, spontaneous regression rates for
cervical dysplasia in nonpregnant women
were reported as 62%, 33%, and 19% for
mild, moderate and severe dysplasia, res-
pectively20. Studies on regression rates of
dysplasia during pregnancy have found
higher regression rates in the postpar-
tum period compared with rates in non-
pregnant women13,14,18.
A purpose of this study was to deter-
mine whether abnormal antepartum cer-
vical cytologic findings result in differing
postpartum regression rates. In this stu-
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TABLE 3














CIS – CIN III
CIN I – – – – – –
CIN II 1 3 8 1 – 13
CIN III – – 1 5 2 8
Total 1 3 9 6 2 21
dy, 107 pregnant women were originally
identified with abnormal antepartum cer
-vical cytologic findings. A follow-up post-
partum period of six months was chosen
because it has been suggested by many
authors2–6,12–14 that this period is enough
for development of cytologic finding of cer-
vical dysplasia. In addition, it is standard
to repeat evaluation of the dysplasia 6
months after delivery. In our study the
overall postpartum regression rate for
women with dysplasia was 57% (61 of 107
women). Others reported spontaneous re-
gression rates of 30% to 54% in preg-
nancy12–14,18,21–26. Also, 50 of 107 (46.7%)
antepartum abnormal Papanicolaou sme-
ars became normal postpartum. There is
good agreement between our results and
those of others21–26. Therefore our study
supports these previous studies and the
clinical observation that the spontaneous
regression of cervical dysplasia occurs
with increased frequency in the postpar-
tum period. There was minimal progres-
sion of the antepartum Papanicolaou
smears in only 3 (3%) patients.
On the basis of these observations,
perhaps factors associated with parturi-
tion could be implicated. Desquamation
of the cervical epithelium or enhance-
ment of a localized reparative immuno-
logic response after vaginal delivery
could play an important role in the spon-
taneous regression of cervical dysplasia
in the postpartum period.
To further answer this question it
would be optimal to follow up a cohort of
patients prospectively during pregnancy,
including immunohistochemical analysis.
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UTJECAJ PORODA NA POBOLJ[ANJE NENORMALNIH
CERVIKALNIH CITOLO[KIH NALAZA
S A @ E T A K
Cilj istra`ivanja bio je odrediti nenormalne cervikalne citolo{ke nalaze tijekom tru-
dno}e i ispitati njihovo mijenjanje poslije poroda. Izme|u 1993. i 2000. godine pra}eno
je 107 trudnica s nenormalnim cervikalnim citolo{kim nalazima. Papanikolaou testovi
podijeljeni su u tri skupine prema CIN klasifikaciji. Analizirano je njihovo pobolj{anje
{est mjeseci poslije poroda. Normalizacija Papanikolaou nalaza u razdoblju poslije po-
roda uo~ena je u 50 od 107 `ena (46.7%). Pobolj{anje cervikalnih citolo{kih nalaza na-
|ena je u 61 od 107 `ena (57%). Nalazi Papanikolaou testova nisu se promijenili u 43
od 107 ispitanica (40%). Samo 3 od 107 (3%) nenormalnih nalaza tijekom trudno}e
pogor{alo se poslije poroda. Lju{tenje cervikalnog epitela ili pobolj{anje lokalnog imu-
nolo{kog sustava poslije poroda mo`ebitno ima va`nu ulogu u spontanoj regresiji cer-
vikalne displazije u razdoblju poslije poroda.
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